Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2015

Nov 16, 2015

29745_dirs_2015-11-16_0c373777-d131-4214-8c16-755eb44b5c8a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-11-12

Reporting Person: Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-12 Common Stock M 6928 $56.18 Acquired 118710 Direct
2015-11-12 Common Stock F 5579 $80.70 Disposed 113131 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-11-12 Employee stock option 2/06 (right to buy) $56.18 M 6928 Disposed 2016-02-09 Common Stock (6928.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4763 Indirect